ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

House Committee Adds $4.1 Billion To HHS Budget, Funds Not Expected To Help NIH.

May 12, 2006